Previously, mass spectrometric characterization of KRAS expressed in pancreatic and colorectal cancer cells have shown that KRAS, like most eukaryotic proteins, undergoes N-terminal methionine excision and N-terminal acetylation24,25. The gene discussed is KRAS; the disease is colorectal cancer.